Research Analysts’ ratings reiterations for Tuesday, February 26th:
Robert Walters (LON: RWA) had its buy rating reissued by analysts at Investec. The firm currently has a $3.56 target price on the stock.
Robert Walters (LON: RWA) had its sell rating reiterated by analysts at Panmure Gordon. The firm currently has a $1.90 price target on the stock.
Robert Walters (LON: RWA) had its sell rating reissued by analysts at Seymour Pierce. Seymour Pierce currently has a $2.50 target price on the stock.
Steven Madden (NASDAQ: SHOO) had its sell rating reiterated by analysts at Goldman Sachs. The firm currently has a $35.00 price target on the stock.
Shire PLC (NASDAQ: SHPGY) had its buy rating reaffirmed by analysts at Deutsche Bank.
Sirius XM Radio (NASDAQ: SIRI) had its hold rating reiterated by analysts at Wunderlich. The analysts wrote, “Yesterday, at the Mobile World Congress, GM indicated that 2014 vehicles across all lines will be equipped with 4G mobile broadband technology. There is particular intent to favor telematics application to complement Onstar, with telematics also important to Liberty Media’s (LMCA-$106.42, Hold) plans for SIRI. This could leapfrog GM ahead of Ford (F-NR) Sync and the balky but now improved MyFord Touch. The 4G system includes backseat video as well as social media such as Facebook (FB-NR) and Twitter.”
Standard Life (LON: SL) had its buy rating reiterated by analysts at Panmure Gordon. Panmure Gordon currently has a $5.69 price target on the stock.
ST Modwen Properties (LON: SMP) had its neutral rating reaffirmed by analysts at Espirito Santo Investment Bank Research. Espirito Santo Investment Bank Research currently has a $3.38 target price on the stock.
Senior (LON: SNR) had its buy rating reaffirmed by analysts at Citigroup. Citigroup currently has a $4.20 price target on the stock.
Sports Direct International (LON: SPD) had its buy rating reaffirmed by analysts at Oriel Securities Ltd. They currently have a $7.73 price target on the stock.
Spirent Communications (LON: SPT) had its buy rating reissued by analysts at Panmure Gordon. They currently have a $2.91 price target on the stock.
Travis Perkins (LON: TPK) had its neutral rating reaffirmed by analysts at UBS AG. The firm currently has a $18.95 target price on the stock.
Topps Tiles PLC (LON: TPT) had its buy rating reaffirmed by analysts at Espirito Santo Investment Bank Research. The firm currently has a $0.83 target price on the stock.
Transfield Services (ASX: TSE) had its neutral rating reaffirmed by analysts at Credit Suisse. The firm currently has a $2.11 price target on the stock.
Trina Solar (NYSE: TSL) had its hold rating reissued by analysts at Deutsche Bank.
Grupo Televisa S.A. (NYSE: TV) had its sector perform rating reissued by analysts at Scotiabank.
UniCredit SpA (BIT: UCG) had its reduce rating reaffirmed by analysts at Oddo & Cie. Oddo & Cie currently has a $3.90 price target on the stock.
United Parcel Service (NYSE: UPS) had its overweight rating reiterated by analysts at JPMorgan Chase. They currently have a $84.00 target price on the stock.
Vivendi SA (EPA: VIV) had its buy rating reiterated by analysts at Jefferies Group. The firm currently has a $24.68 target price on the stock.
Valero Energy (NYSE: VLO) had its outperform rating reissued by analysts at Oppenheimer. Oppenheimer currently has a $55.00 target price on the stock.
Virgin Media Plc (LON: VMED) had its neutral rating reaffirmed by analysts at Espirito Santo Investment Bank Research. They currently have a $44.73 price target on the stock.
Vodafone Group plc (LON: VOD) had its overweight rating reaffirmed by analysts at JPMorgan Chase. The firm currently has a $3.34 target price on the stock.
Vodafone Group plc (LON: VOD) had its hold rating reissued by analysts at Deutsche Bank. The firm currently has a $2.62 target price on the stock.
Volcano (NASDAQ: VOLC) had its neutral rating reaffirmed by analysts at Zacks. The firm currently has a $23.00 target price on the stock. Zacks’ analyst wrote, “Volcano’s fourth quarter performance was dismal with EPS of $0.04 missing the Zacks Consensus Estimate by $0.05 as well as the year-ago EPS of $0.54. Revenues were up 12% at CER, in line with the Zacks Consensus Estimate. Several challenges currently at play forced the company to take a conservative 2013 outlook. Despite the importance of Japan in development of the IVUS business, the quarter’s performance was disappointing impacted negatively by a 10% cut in reimbursement. However, we are encouraged with the company’s pipeline development, with many products, slated for release over the next few quarters. We also believe that favorable industry trends should aid the growth of the company. At present clinicians and hospitals are facing increasing pressure to justify the medical necessity of PCI therapy. However, margins still remain under pressure. Accordingly, we remain Neutral on the stock. “
Vitamin Shoppe (NYSE: VSI) had its neutral rating reiterated by analysts at Wedbush.
